Publications by authors named "Marc Pondel"

Claim this Profile
B
Budget impact analysis of pembrolizumab versus the novel PD-1 inhibitor toripalimab in locally advanced or metastatic nonsquamous non-small cell lung cancer.
Ivo Abraham, Matthias Calamia, Nimer Alkhatib, Marc Pondel, Karen MacDonald

J Med Econ· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Budget impact analysis of the novel PD-1 inhibitor toripalimab versus pembrolizumab in recurrent or metastatic nasopharyngeal carcinoma.
Ivo Abraham, Matthias Calamia, Nimer Alkhatib, Marc Pondel, Karen MacDonald

J Med Econ· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-efficiency and budget-neutral expanded access modeling of pembrolizumab versus the novel PD-1 inhibitor toripalimab in locally advanced or metastatic nonsquamous non-small cell lung cancer.
Karen MacDonald, Marc Pondel, Ivo Abraham

J Med Econ· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-efficiency and budget-neutral expanded access modeling of the novel PD-1 inhibitor toripalimab versus pembrolizumab in recurrent or metastatic nasopharyngeal carcinoma.
Karen MacDonald, Marc Pondel, Ivo Abraham

J Med Econ· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cloning and transcriptional analysis of the mouse receptor activity modifying protein-1 gene promoter.
Marc D Pondel, Richard Mould

BMC Mol Biol· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Calcitonin receptor gene expression in K562 chronic myelogenous leukemic cells.
Richard Mould, Marc D Pondel

Cancer Cell Int· April 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis